Key | % Net Assets |
---|---|
Royal Dutch Shell Plc 'B' | 6.8% |
BG Group Plc | 6.3% |
GlaxoSmithKline Plc | 5.9% |
Vodafone Group Plc | 4.8% |
Other | 76.2% |
Name | % Net Assets |
---|---|
Royal Dutch Shell Plc 'B' | 6.8% |
BG Group Plc | 6.3% |
GlaxoSmithKline Plc | 5.9% |
Vodafone Group Plc | 4.8% |
Anglo American Plc | 4.8% |
Unilever Plc | 4.8% |
BP Plc | 4.2% |
Centrica Plc | 3.6% |
HSBC Holdings | 3.3% |
AstraZeneca Plc | 2.6% |
No asset data available.
Date | n/a |
---|---|
Bid | 0.00 |
Offer | 0.00 |
Currency | n/a |
Change | 0.00 |
% | n/a |
YTD change | 0.00 |
YTD % | n/a |
Fund Inception | 01/11/1999 |
---|---|
Fund Manager | Jeremy Smith |
TER | - |
Minimum Investment | |
---|---|
Initial | 500000 |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | 3.00% |
Annual Mang't | 0.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.01 |
Sharpe ratio | 0.19 |
You are here: research